ADIPOQ and type 2 diabetes mellitus: Adiponectin secretion in humans is suppressed by enhanced hormonal activity of the visceral lipid tissue, which is induced by weight gain and which is associated with the development of metabolic syndrome and type 2 diabetes mellitus [2].